ROME IV FGIDs | Chapter 6: Age, Gender, and Women’s Health and the Patient

ROME IV FGIDs | Chapter 5: Pharmacological, Pharmacokinetic, and Pharmacogenomic Aspects of FGIDs

ROME IV FGIDs | Chapter 7: Multicultural Aspects of Functional Gastrointestinal Disorders

Helman CG. Communication in primary care: the role of patient and practitioner explanatory models. Soc Sci Med 1985;20:923-931.
Heidelbaugh JJ, Stelwagon M, Miller SA, et al. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden. Am J Gastroenterol 2015;110:580-587.
Halpert A, Rybin D, Doros G. Expressive writing is a promising therapeutic modality for the management of IBS: a pilot study. Am J Gastroenterol 2010;105:2440-2448.
Halpert A, Godena E. Irritable bowel syndrome patients’ perspectives on their relationships with healthcare providers. Scand J Gastroenterol 2011;46:823-830.
Drossman DA, Chang L, Schneck S, et al. A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity. Dig Dis Sci 2009;54:1532-1541.
Halpert A, Dalton CB, Diamant NE, et al. Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage. Am J Gastroenterol 2005;100:664-671.
International Foundation for Functional Gastrointestinal Disorders. IBS in the real world survey. Available at: http://www.iffgd.org/site/news-events/press-releases/2002-0423-ibs-in-real-world. Accessed January 29, 2014.
Kwan YH, Koh ET, Leong KP, et al. Association between helplessness, disability, and disease activity with health-related quality of life among rheumatoid arthritis patients in a multiethnic Asian population. Rheumatol Int 2014;34:1085-1093.
Bertram S, Kurland M, Lydick E, et al. The patient’s perspective of irritable bowel syndrome. J Fam Pract 2001;50:521-525.
Håkanson C. Everyday life, healthcare, and self-care management among people with irritable bowel syndrome: an integrative review of qualitative research. Gastroenterol Nurs 2014;37:217-225.
Hungin AP, Chang L, Locke GR, et al. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005;21:1365-1375.
Verne GN. The public awareness of the prevalence and impact of irritable bowel syndrome in the United States: perception versus reality. J Clin Gastroenterol 2004;38:419-424.
Heaton KW, O’Donnell LJ, Braddon FE, et al. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 1992;102:1962-1967.
American College of Gastroenterology (ACG). ACG patients home / digestive health topic / irritable bowel syndrome. Available at: http://patients.gi.org/topics/irritable-bowel-syndrome/. Accessed 2014.
Heitkemper M, Carter E, Ameen V, et al. Women with irritable bowel syndrome: differences in patients’ and physicians’ perceptions. Gastroenterol Nurs 2002;25:192-200.
Halpert A, Dalton CB, Palsson O, et al. Irritable bowel syndrome patients’ ideal expectations and recent experiences with healthcare providers: a national survey. Dig Dis Sci 2010;55:375-383.
Lacy BE, Weiser K, Noddin L, et al. Irritable bowel syndrome: patients’ attitudes, concerns and level of knowledge. Aliment Pharmacol Ther 2007;25:1329-1341.
Halpert A. Irritable bowel syndrome: what do patients really want? Curr Gastroenterol Rep 2011;13:331-335.
Halpert A, Dalton CB, Palsson O, et al. What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am J Gastroenterol 2007;102:1972-1982.
Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991;100:998-1005.
Kozma C, Barghout V, Slaton T, et al. A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma. Manag Care Interface 2002;15:40-43, 49.
Olafsdottir LB, Gudjonsson H, Jonsdottir HH, et al. Natural history of irritable bowel syndrome in women and dysmenorrhea: a 10-year follow-up study. Gastroenterol Res Pract 2012;2012:534204.
Lacy BE, Rosemore J, Robertson D, et al. Physicians’ attitudes and practices in the evaluation and treatment of irritable bowel syndrome. Scand J Gastroenterol 2006;41:892-902.
Hamberg K, Risberg G, Johansson EE. Male and female physicians show different patterns of gender bias: a paper-case study of management of irritable bowel syndrome. Scand J Public Health 2004;32:144-152.
Drossman DA. Challenges in the physician-patient relationship: feeling “drained”. Gastroenterology 2001;121:1037-1038.
Raine R, Carter S, Sensky T, et al. General practitioners’ perceptions of chronic fatigue syndrome and beliefs about its management, compared with irritable bowel syndrome: qualitative study. BMJ 2004;328:1354-1357.
Conboy LA, Macklin E, Kelley J, et al. Which patients improve: characteristics increasing sensitivity to a supportive patient-practitioner relationship. Soc Sci Med 2010;70:479-484.
Kaptchuk TJ, Kelley JM, Conboy LA, et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008;336:999-1003.
Dhaliwal SK, Hunt RH. Doctor-patient interaction for irritable bowel syndrome in primary care: a systematic perspective. Eur J Gastroenterol Hepatol 2004;16:1161-1166.
Kennedy A, Robinson A, Rogers A. Incorporating patients’ views and experiences of life with IBS in the development of an evidence-based self-help guidebook. Patient Educ Couns 2003;50:303-310.
Salmon P, Peters S, Stanley I. Patients’ perceptions of medical explanations for somatisation disorders: qualitative analysis. BMJ 1999;318:372-376.
Worell J, Remer P. Feminist perspectives in therapy: empowering diverse women Hoboken, NJ: John Wiley & Sons, 2003.
Tolman DL. In a different position: conceptualizing female adolescent sexuality development within compulsory heterosexuality. New Dir Child Adolesc Dev 2006:71-89.
Jack DC. Silencing the self: women and depression. Cambridge, MA: Harvard University Press, 1991.
van Daalen-Smith C. Living as a chameleon: girls, anger, and mental health. J Sch Nurs 2008;24:116-123.
Toner B, Tang T, Ali A, et al. Developing a gender role socialization scale. In: Oliffe JL, Greaves L, eds. Designing and conducting gender, sex, & health research. Thousand Oaks, CA: SAGE Publications, Inc., 2012:189-201.
Boquiren VM, Esplen MJ, Wong J, et al. Exploring the influence of gender-role socialization and objectified body consciousness on body image disturbance in breast cancer survivors. Psychooncology 2013;22:2177-2185.
Toner BB, Akman D. Gender role and irritable bowel syndrome: literature review and hypothesis. Am J Gastroenterol 2000;95:11-16.
Ringel Y, Williams RE, Kalilani L, et al. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2009;7:68-72; quiz 63.
Cheney AM. “Most girls want to be skinny”: body (dis)satisfaction among ethnically diverse women. Qual Health Res 2011;21:1347-1359.
Kambarami M. Femininity, sexuality and culture: patriarchy and female subordination in Zimbabwe. South Africa: ARSRC 2006.
Bepko C, Krestan J-A. Too good for her own good. New York, NY: Harper and Row, 1990.
Jack DC. Silencing the self: inner dialogues and outer realities. In: Joiner T, Coyne J, eds. The interactional nature of depression: advances in interpersonal approaches. Washington, DC: American Psychological Association, 1999:221-246.
Ali A, Toner BB, Stuckless N, et al. Emotional abuse, self-blame, and self-silencing in women with irritable bowel syndrome. Psychosom Med 2000;62:76-82.
Bjorkman I, Dellenborg L, Ringstrom G, et al. The gendered impact of irritable bowel syndrome: a qualitative study of patients’ experiences. J Adv Nurs 2013;70:1334-1343.
Lackner JM, Gudleski GD, Firth R, et al. Negative aspects of close relationships are more strongly associated than supportive personal relationships with illness burden of irritable bowel syndrome. J Psychosom Res 2013;74:493-500.
Dinan TG, O’Keane V, O’Boyle C, et al. A comparison of the mental status, personality profiles and life events of patients with irritable bowel syndrome and peptic ulcer disease. Acta Psychiatr Scand 1991;84:26-28.
Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701-708.
Drossman DA, Sandler RS, McKee DC, et al. Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 1982;83:529-534.
Fava GA, Pavan L. Large bowel disorders. II. Psychopathology and alexithymia. Psychother Psychosom 1976;27:100-105.
Levy RL, Cain KC, Jarrett M, et al. The relationship between daily life stress and gastrointestinal symptoms in women with irritable bowel syndrome. J Behav Med 1997;20:177-193.
Mendeloff AI, Monk M, Siegel CI, et al. Illness experience and life stresses in patients with irritable colon and with ulcerative colitis. An epidemiologic study of ulcerative colitis and regional enteritis in Baltimore, 1960-1964. N Engl J Med 1970;282:14-17.
Miwa H. Lifestyle in persons with functional gastrointestinal disorders—large-scale internet survey of lifestyle in Japan. Neurogastroenterol Motil 2012;24:464-471, e217.
Walker LS, Garber J, Smith CA, et al. The relation of daily stressors to somatic and emotional symptoms in children with and without recurrent abdominal pain. J Consult Clin Psychol 2001;69:85-91.
Whitehead WE, Crowell MD, Robinson JC, et al. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992;33:825-830.
Heitkemper MM, Cain KC, Deechakawan W, et al. Anticipation of public speaking and sleep and the hypothalamic-pituitary-adrenal axis in women with irritable bowel syndrome. Neurogastroenterol Motil 2012;24:626-631, e270-621.
Creed F, Craig T, Farmer R. Functional abdominal pain, psychiatric illness, and life events. Gut 1988;29:235-242.
Drossman DA, Li Z, Leserman J, et al. Health status by gastrointestinal diagnosis and abuse history. Gastroenterology 1996;110:999-1007.
Monnikes H, Tebbe JJ, Hildebrandt M, et al. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig Dis 2001;19:201-211.
Riedl A, Maass J, Fliege H, et al. Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome. J Psychosom Res 2009;67:449-455.
Bennett EJ, Tennant CC, Piesse C, et al. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998;43:256-261.
Lackner JM, Gudleski GD, Thakur ER, et al. The impact of physical complaints, social environment, and psychological functioning on IBS patients’ health perceptions: looking beyond GI symptom severity. Am J Gastroenterol 2014;109:224-233.
Maguen S, Madden E, Cohen B, et al. Association of mental health problems with gastrointestinal disorders in Iraq and Afghanistan veterans. Depress Anxiety 2014;31:160-165.
Bradford K, Shih W, Videlock EJ, et al. Association between early adverse life events and irritable bowel syndrome. Clin Gastroenterol Hepatol 2012;10:385-390.e381-383.
Talley NJ, Boyce P, Owen BK. Psychological distress and seasonal symptom changes in irritable bowel syndrome. Am J Gastroenterol 1995;90:2115-2119.
Walker EA, Katon WJ, Roy-Byrne PP, et al. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry 1993;150:1502-1506.
Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig Dis Sci 1993;38:1581-1589.
Goodwin L, White PD, Hotopf M, et al. Life course study of the etiology of self-reported irritable bowel syndrome in the 1958 British birth cohort. Psychosom Med 2013;75:202-210.
Jones MP, Oudenhove LV, Koloski N, et al. Early life factors initiate a ‘vicious circle’ of affective and gastrointestinal symptoms: a longitudinal study. United European Gastroenterol J 2013;1:394-402.
Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003;125:19-31.
Nellesen D, Yee K, Chawla A, et al. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Manag Care Pharm 2013;19:755-764.
Tang YR, Yang WW, Wang YL, et al. Sex differences in the symptoms and psychological factors that influence quality of life in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2012;24:702-707.
Simren M, Abrahamsson H, Svedlund J, et al. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001;36:545-552.
Dancey C, Hutton-Young S, Moye S, et al. Perceived stigma, illness intrusiveness and quality of life in men and women with irritable bowel syndrome. Psychol Health Med 2002;7:381-395.
Koloski NA, Talley NJ, Boyce PM. Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community cohort study. Am J Gastroenterol 2003;98:789-797.
Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-1580.
Locke GR, 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-1456.
Gale CR, Wilson JA, Deary IJ. Globus sensation and psychopathology in men: the Vietnam experience study. Psychosom Med 2009;71:1026-1031.
Chial HJ, Camilleri M, Williams DE, et al. Rumination syndrome in children and adolescents: diagnosis, treatment, and prognosis. Pediatrics 2003;111:158-162.
Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479.
Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting—a population-based study. Aliment Pharmacol Ther 2003;17:1115-1124.
Fass R, Achem SR. Noncardiac chest pain: epidemiology, natural course and pathogenesis. J Neurogastroenterol Motil 2011;17:110-123.
Cormier LE, Katon W, Russo J, et al. Chest pain with negative cardiac diagnostic studies. Relationship to psychiatric illness. J Nerv Ment Dis 1988;176:351-358.
Mousavi S, Tosi J, Eskandarian R, et al. Role of clinical presentation in diagnosing reflux-related non-cardiac chest pain. J Gastroenterol Hepatol 2007;22:218-221.
Fass R, Sampliner RE, Mackel C, et al. Age- and gender-related differences in 24-hour esophageal pH monitoring of normal subjects. Dig Dis Sci 1993;38:1926-1928.
Ter RB. Gender differences in gastroesophageal reflux disease. J Gend Specif Med 2000;3:42-44.
Ter RB, Johnston BT, Castell DO. Influence of age and gender on gastroesophageal reflux in symptomatic patients. Dis Esophagus 1998;11:106-108.
Ronkainen J, Agreus L. Epidemiology of reflux symptoms and GORD. Best Pract Res Clin Gastroenterol 2013;27:325-337.
Aro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 2009;137:94-100.
Choung RS, Locke GR, Schleck CD, et al. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol 2007;102:1983-1989.
Zagari RM, Law GR, Fuccio L, et al. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology 2010;138:1302-1311.
Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992;102:1259-1268.
Tack J, Talley NJ. Functional dyspepsia—symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol 2013;10:134-141.
Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-1042.
Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 2001;96:1422-1428.
Strid H, Norstrom M, Sjoberg J, et al. Impact of sex and psychological factors on the water loading test in functional dyspepsia. Scand J Gastroenterol 2001;36:725-730.
Talley NJ, Locke GR, 3rd, Lahr BD, et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut 2006;55:933-939.
Frexinos J, Denis P, Allemand H, et al. Descriptive study of digestive functional symptoms in the French general population. Gastroenterol Clin Biol 1998;22:785-791.
Chitkara DK, Bredenoord AJ, Rucker MJ, et al. Aerophagia in adults: a comparison with functional dyspepsia. Aliment Pharmacol Ther 2005;22:855-858.
Devanarayana NM, Rajindrajith S. Aerophagia among Sri Lankan schoolchildren: epidemiological patterns and symptom characteristics. J Pediatr Gastroenterol Nutr 2012;54:516-520.
Sagawa T, Okamura S, Kakizaki S, et al. Functional gastrointestinal disorders in adolescents and quality of school life. J Gastroenterol Hepatol 2013;28:285-290.
Agreus L, Svardsudd K, Nyren O, et al. The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptom Study. Scand J Gastroenterol 1994;29:102-109.
Talley NJ, O’Keefe EA, Zinsmeister AR, et al. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992;102:895-901.
Talley NJ, Zinsmeister AR, Van Dyke C, et al. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927-934.
Ladep NG, Okeke EN, Samaila AA, et al. Irritable bowel syndrome among patients attending general outpatients’ clinics in Jos, Nigeria. Eur J Gastroenterol Hepatol 2007;19:795-799.
Muller-Lissner S. Epidemiology of irritable bowel syndrome in irritable bowel syndrome: diagnosis and clinical management. Boston, MA: Wiley-Blackwell, 2013.
Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol 2012;107:991-1000.
Locke GR, 3rd. The epidemiology of functional gastrointestinal disorders in North America. Gastroenterol Clin North Am 1996;25:1-19.
Farmer AD, Coen SJ, Kano M, et al. Psychophysiological responses to visceral and somatic pain in functional chest pain identify clinically relevant pain clusters. Neurogastroenterol Motil 2014;26:139-148.
Jones LA, Chin LT, Longo DL, et al. Peripheral clonal elimination of functional T cells. Science 1990;250:1726-1729.
Kay L, Jorgensen T. Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol 1994;29:2-6.
Heetun ZS, Zeb F, Cullen G, et al. Biliary sphincter of Oddi dysfunction: response rates after ERCP and sphincterotomy in a 5-year ERCP series and proposal for new practical guidelines. Eur J Gastroenterol Hepatol 2011;23:327-333.
Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990;99:409-415.
Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol 2014;6:71-80.
Keshteli AH, Dehestani B, Daghaghzadeh H, et al. Epidemiological features of irritable bowel syndrome and its subtypes among Iranian adults. Ann Gastroenterol 2015;28:253-258.
Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol 1996;91:19-25.
Bennett G, Talley NJ. Irritable bowel syndrome in the elderly. Best Pract Res Clin Gastroenterol 2002;16:63-76.
Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998;42:690-695.
Garrigues V, Galvez C, Ortiz V, et al. Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol 2004;159:520-526.
Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 2007;25:599-608.
Choung RS, Branda ME, Chitkara D, et al. Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther 2011;33:251-260.
Wong ML, Wee S, Pin CH, et al. Sociodemographic and lifestyle factors associated with constipation in an elderly Asian community. Am J Gastroenterol 1999;94:1283-1291.
Wei X, Chen M, Wang J. The epidemiology of irritable bowel syndrome and functional constipation of Guangzhou residents. Zhonghua Nei Ke Za Zhi 2001;40:517-520.
Chen GD, Hu SW, Chen YC, et al. Prevalence and correlations of anal incontinence and constipation in Taiwanese women. Neurourol Urodyn 2003;22:664-669.
Sandler RS, Stewart WF, Liberman JN, et al. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci 2000;45:1166-1171.
Jiang X, Locke GR, 3rd, Choung RS, et al. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut 2008;57:756-763.
Schmulson M, Adeyemo M, Gutierrez-Reyes G, et al. Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population. Am J Gastroenterol 2010;105:925-932.
Walker LS, Sherman AL, Bruehl S, et al. Functional abdominal pain patient subtypes in childhood predict functional gastrointestinal disorders with chronic pain and psychiatric comorbidities in adolescence and adulthood. Pain 2012;153:1798-1806.
Edwards NI, Jones D. The prevalence of faecal incontinence in older people living at home. Age Ageing 2001;30:503-507.
Rizk DE, Hassan MY, Shaheen H, et al. The prevalence and determinants of health care-seeking behavior for fecal incontinence in multiparous United Arab Emirates females. Dis Colon Rectum 2001;44:1850-1856.
Nelson R, Furner S, Jesudason V. Fecal incontinence in Wisconsin nursing homes: prevalence and associations. Dis Colon Rectum 1998;41:1226-1229.
Talley NJ, Weaver AL, Zinsmeister AR, et al. Functional constipation and outlet delay: a population-based study. Gastroenterology 1993;105:781-790.
Stewart WF, Liberman JN, Sandler RS, et al. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999;94:3530-3540.
Sung VW, Hampton BS. Epidemiology of pelvic floor dysfunction. Obstet Gynecol Clin North Am 2009;36:421-443.
Bitti GT, Argiolas GM, Ballicu N, et al. Pelvic floor failure: MR imaging evaluation of anatomic and functional abnormalities. Radiographics 2014;34:429-448.
van der Horst HE, van Dulmen AM, Schellevis FG, et al. Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome? Gut 1997;41:669-674.
Taub E, Cuevas JL, Cook EW, 3rd, et al. Irritable bowel syndrome defined by factor analysis. Gender and race comparisons. Dig Dis Sci 1995;40:2647-2655.
Lee OY, Mayer EA, Schmulson M, et al. Gender-related differences in IBS symptoms. Am J Gastroenterol 2001;96:2184-2193.
Talley NJ, Zinsmeister AR, Melton LJ, 3rd. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995;142:76-83.
Heitkemper MM, Cain KC, Jarrett ME, et al. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Am J Gastroenterol 2003;98:420-430.
Heitkemper MM, Jarrett M, Cain KC, et al. Daily gastrointestinal symptoms in women with and without a diagnosis of IBS. Dig Dis Sci 1995;40:1511-1519.
Houghton LA, Lea R, Jackson N, et al. The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut 2002;50:471-474.
Whitehead WE, Cheskin LJ, Heller BR, et al. Evidence for exacerbation of irritable bowel syndrome during menses. Gastroenterology 1990;98:1485-1489.
Jane ZY, Chang CC, Lin HK, et al. The association between the exacerbation of irritable bowel syndrome and menstrual symptoms in young Taiwanese women. Gastroenterol Nurs 2011;34:277-286.
Everhart JE, Go VL, Johannes RS, et al. A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci 1989;34:1153-1162.
Pare P, Ferrazzi S, Thompson WG, et al. An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001;96:3130-3137.
Peppas G, Alexiou VG, Mourtzoukou E, et al. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol 2008;8:5.
Siproudhis L, Pigot F, Godeberge P, et al. Defecation disorders: a French population survey. Dis Colon Rectum 2006;49:219-227.
McCrea GL, Miaskowski C, Stotts NA, et al. Gender differences in self-reported constipation characteristics, symptoms, and bowel and dietary habits among patients attending a specialty clinic for constipation. Gend Med 2009;6:259-271.
Zhao YF, Ma XQ, Wang R, et al. Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC). Aliment Pharmacol Ther 2011;34:1020-1029.
Zhao YF, Guo XJ, Zhang ZS, et al. Epidemiology of functional diarrhea and comparison with diarrhea-predominant irritable bowel syndrome: a population-based survey in China. PLoS One 2012;7:e43749.
Talley NJ, Weaver AL, Zinsmeister AR, et al. Self-reported diarrhea: what does it mean? Am J Gastroenterol 1994;89:1160-1164.
Jeong JJ, Choi MG, Cho YS, et al. Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol 2008;14:6388-6394.
Ford AC, Moayyedi P. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther 2010;32:144-158.
Quigley EM, Locke GR, Mueller-Lissner S, et al. Prevalence and management of abdominal cramping and pain: a multinational survey. Aliment Pharmacol Ther 2006;24:411-419.
Lynch AC, Dobbs BR, Keating J, et al. The prevalence of faecal incontinence and constipation in a general New Zealand population; a postal survey. N Z Med J 2001;114:474-477.
Perry S, Shaw C, McGrother C, et al. Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut 2002;50:480-484.
Walter S, Hallbook O, Gotthard R, et al. A population-based study on bowel habits in a Swedish community: prevalence of faecal incontinence and constipation. Scand J Gastroenterol 2002;37:911-916.
Thompson WG. Proctalgia fugax. Dig Dis Sci 1981;26:1121-1124.
Sperber AD, Dekel R. Irritable bowel syndrome and co-morbid gastrointestinal and extra-gastrointestinal functional syndromes. J Neurogastroenterol Motil 2010;16:113-119.
Vu J, Kushnir V, Cassell B, et al. The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders. Neurogastroenterol Motil 2014;26:1323-1332.
Lackner JM, Ma CX, Keefer L, et al. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013;11:1147-1157.
Chang FY, Lu CL. Irritable bowel syndrome and migraine: bystanders or partners? J Neurogastroenterol Motil 2013;19:301-311.
Rodrigo L, Blanco I, Bobes J, et al. Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study. Arthritis Res Ther 2013;15:R201.
Przekop P, Haviland MG, Zhao Y, et al. Self-reported physical health, mental health, and comorbid diseases among women with irritable bowel syndrome, fibromyalgia, or both compared with healthy control respondents. J Am Osteopath Assoc 2012;112:726-735.
Warren JW, Langenberg P, Clauw DJ. The number of existing functional somatic syndromes (FSSs) is an important risk factor for new, different FSSs. J Psychosom Res 2013;74:12-17.
Shelby GD, Shirkey KC, Sherman AL, et al. Functional abdominal pain in childhood and long-term vulnerability to anxiety disorders. Pediatrics 2013;132:475-482.
Rodriguez MA, Afari N, Buchwald DS. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol 2009;182:2123-2131.
Nguyen RH, Veasley C, Smolenski D. Latent class analysis of comorbidity patterns among women with generalized and localized vulvodynia: preliminary findings. J Pain Res 2013;6:303-309.
Fass R, Fullerton S, Naliboff B, et al. Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia. Digestion 1998;59:79-85.
Altman G, Cain KC, Motzer S, et al. Increased symptoms in female IBS patients with dysmenorrhea and PMS. Gastroenterol Nurs 2006;29:4-11.
Crowell MD, Dubin NH, Robinson JC, et al. Functional bowel disorders in women with dysmenorrhea. Am J Gastroenterol 1994;89:1973-1977.
Mathur R, Ko A, Hwang LJ, et al. Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome. Dig Dis Sci 2010;55:1085-1089.
Hasler WL, Schoenfeld P. Systematic review: abdominal and pelvic surgery in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:997-1005.
Brown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev 2014;3:Cd009590.
Seaman HE, Ballard KD, Wright JT, et al. Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: findings from a national case-control study—part 2. BJOG 2008;115:1392-1396.
Smorgick N, Marsh CA, As-Sanie S, et al. Prevalence of pain syndromes, mood conditions, and asthma in adolescents and young women with endometriosis. J Pediatr Adolesc Gynecol 2013;26:171-175.
Issa B, Onon TS, Agrawal A, et al. Visceral hypersensitivity in endometriosis: a new target for treatment? Gut 2012;61:367-372.
Soumekh A, Nagler J. Gastrointestinal endometriosis causing subacute intestinal obstruction with gradual development of weight loss and misdiagnosed as irritable bowel syndrome. Case Rep Gastroenterol 2014;8:51-55.
Brucker SY, Huebner M, Wallwiener M, et al. Clinical characteristics indicating adenomyosis coexisting with leiomyomas: a retrospective, questionnaire-based study. Fertil Steril 2014;101:237-241.e231.
Won HR, Abbott J. Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approach. Int J Womens Health 2010;2:263-277.
Eugenio MD, Jun SE, Cain KC, et al. Comprehensive self-management reduces the negative impact of irritable bowel syndrome symptoms on sexual functioning. Dig Dis Sci 2012;57:1636-1646.
Hasler W, Schoenfeld P. Abdominal and pelvic surgery in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:997-1005.
Warren JW, Clauw DJ, Wesselmann U, et al. Functional somatic syndromes as risk factors for hysterectomy in early bladder pain syndrome/interstitial cystitis. J Psychosom Res 2014.
Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004;126:1665-1673.
Robinson BL, Matthews CA, Palsson OS, et al. Obstetric sphincter injury interacts with diarrhea and urgency to increase the risk of fecal incontinence in women with IBS. Female Pelvic Med Reconstr Surg 2013;19:40.
Khoshbaten M, Melli MS, Fattahi MJ, et al. Irritable bowel syndrome in women undergoing hysterectomy and tubular ligation. Gastroenterol Hepatol Bed Bench 2011;4:138-141.
Lee YC, Wang HP, Chiu HM, et al. Factors determining post-colonoscopy abdominal pain: prospective study of screening colonoscopy in 1000 subjects. J Gastroenterol Hepatol 2006;21:1575-1580.
Kennedy TM, Jones RH. The epidemiology of hysterectomy and irritable bowel syndrome in a UK population. Int J Clin Pract 2000;54:647-650.
Brawman-Mintzer O, Durkalski V, Wu Q, et al. Psychosocial characteristics and pain burden of patients with suspected sphincter of Oddi dysfunction in the EPISOD multicenter trial. Am J Gastroenterol 2014;109:436-442.
Nojkov B, Rubenstein JH, Chey WD, et al. The impact of rotating shift work on the prevalence of irritable bowel syndrome in nurses. Am J Gastroenterol 2010;105:842-847.
Jarrett M, Heitkemper M, Cain KC, et al. Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome. Dig Dis Sci 2000;45:952-959.
Wahner-Roedler DL, Olson EJ, Narayanan S, et al. Gender-specific differences in a patient population with obstructive sleep apnea-hypopnea syndrome. Gend Med 2007;4:329-338.
Holdcroft A, Sapsed-Byrne S, Ma D, et al. Sex and oestrous cycle differences in visceromotor responses and vasopressin release in response to colonic distension in male and female rats anaesthetized with halothane. Br J Anaesth 2000;85:907-910.
Ji Y, Murphy AZ, Traub RJ. Sex differences in morphine-induced analgesia of visceral pain are supraspinally and peripherally mediated. Am J Physiol Regul Integr Comp Physiol 2006;291:R307-314.
Traub RJ, Ji Y. Sex differences and hormonal modulation of deep tissue pain. Front Neuroendocrinol 2013;34:350-366.
Larauche M, Mulak A, Kim YS, et al. Visceral analgesia induced by acute and repeated water avoidance stress in rats: sex difference in opioid involvement. Neurogastroenterol Motil 2012;24:1031-e1547.
Larsson M, Arvidsson S, Ekman C, et al. A model for chronic quantitative studies of colorectal sensitivity using balloon distension in conscious mice—effects of opioid receptor agonists. Neurogastroenterol Motil 2003;15:371-381.
Kamp EH, Jones RC, 3rd, Tillman SR, et al. Quantitative assessment and characterization of visceral nociception and hyperalgesia in mice. Am J Physiol Gastrointest Liver Physiol 2003;284:G434-G444.
Wang Z, Guo Y, Bradesi S, et al. Sex differences in functional brain activation during noxious visceral stimulation in rats. Pain 2009;145:120-128.
Laird JM, Martinez-Caro L, Garcia-Nicas E, et al. A new model of visceral pain and referred hyperalgesia in the mouse. Pain 2001;92:335-342.
Rudick CN, Pavlov VI, Chen MC, et al. Gender specific pelvic pain severity in neurogenic cystitis. J Urol 2012;187:715-724.
Boucher M, Meen M, Codron JP, et al. Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain. J Urol 2000;164:203-208.
Affaitati G, Ceccarelli I, Fiorenzani P, et al. Sex differences in the analgesic effects of ICI 182,780 and flutamide on ureteral calculosis in rats. Horm Behav 2011;59:9-13.
Aloisi AM, Affaitati G, Ceccarelli I, et al. Estradiol and testosterone differently affect visceral pain-related behavioural responses in male and female rats. Eur J Pain 2010;14:602-607.
Ji Y, Tang B, Cao DY, et al. Sex differences in spinal processing of transient and inflammatory colorectal stimuli in the rat. Pain 2012;153:1965-1973.
Black LV, Ness TJ, Robbins MT. Effects of oxytocin and prolactin on stress-induced bladder hypersensitivity in female rats. J Pain 2009;10:1065-1072.
Bradesi S, Eutamene H, Garcia-Villar R, et al. Stress-induced visceral hypersensitivity in female rats is estrogen-dependent and involves tachykinin NK1 receptors. Pain 2003;102:227-234.
Chaloner A, Greenwood-Van Meerveld B. Early life adversity as a risk factor for visceral pain in later life: importance of sex differences. Front Neurosci 2013;7:13.
LaPrairie JL, Murphy AZ. Female rats are more vulnerable to the long-term consequences of neonatal inflammatory injury. Pain 2007;132 Suppl 1:S124-133.
Meleine M, Matricon J. Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones. World J Gastroenterol 2014;20:6725-6743.
Greenspan JD, Craft RM, LeResche L, et al. Studying sex and gender differences in pain and analgesia: a consensus report. Pain 2007;132 Suppl 1:S26-45.
Cason AM, Samuelsen CL, Berkley KJ. Estrous changes in vaginal nociception in a rat model of endometriosis. Horm Behav 2003;44:123-131.
Craft RM. Modulation of pain by estrogens. Pain 2007;132 Suppl 1:S3-12.
Giamberardino MA, Affaitati G, Valente R, et al. Changes in visceral pain reactivity as a function of estrous cycle in female rats with artificial ureteral calculosis. Brain Res 1997;774:234-238.
Sanoja R, Cervero F. Estrogen-dependent changes in visceral afferent sensitivity. Auton Neurosci 2010;153:84-89.
Gintzler AR, Liu NJ. Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors. Front Neuroendocrinol 2012;33:412-424.
Micevych P. Membrane-initiated estradiol signaling regulates the central nervous system. Front Neuroendocrinol 2012;33:329-330.
Levin ER. Plasma membrane estrogen receptors. Trends Endocrinol Metab 2009;20:477-482.
Dun SL, Brailoiu GC, Gao X, et al. Expression of estrogen receptor GPR30 in the rat spinal cord and in autonomic and sensory ganglia. J Neurosci Res 2009;87:1610-1619.
Qiu J, Bosch MA, Tobias SC, et al. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 2003;23:9529-9540.
Small KM, Nag S, Mokha SS. Activation of membrane estrogen receptors attenuates opioid receptor-like1 receptor-mediated antinociception via an ERK-dependent non-genomic mechanism. Neuroscience 2013;255:177-190.
Bourdu S, Dapoigny M, Chapuy E, et al. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology 2002;128:1996-2008.
Rosztóczy A, Fioramonti J, Jármay K, et al. Influence of sex and experimental protocol on the effect of maternal deprivation on rectal sensitivity to distension in the adult rat. Neurogastroenterol Motil 2003;15:679-686.
Ness TJ, Lewis-Sides A, Castroman P. Characterization of pressor and visceromotor reflex responses to bladder distention in rats: sources of variability and effect of analgesics. J Urol 2001;165:968-974.
Ji Y, Tang B, Traub RJ. The visceromotor response to colorectal distention fluctuates with the estrous cycle in rats. Neuroscience 2008;154:1562-1567.
Ji Y, Murphy AZ, Traub RJ. Estrogen modulates the visceromotor reflex and responses of spinal dorsal horn neurons to colorectal stimulation in the rat. J Neurosci 2003;23:3908-3915.
Ji Y, Tang B, Traub RJ. Modulatory effects of estrogen and progesterone on colorectal hyperalgesia in the rat. Pain 2005;117:433-442.
Tang B, Ji Y, Traub RJ. Estrogen alters spinal NMDA receptor activity via a PKA signaling pathway in a visceral pain model in the rat. Pain 2008;137:540-549.
Fan J, Yu Lh, Zhang Y, et al. Estrogen altered visceromotor reflex and P2X3 mRNA expression in a rat model of colitis. Steroids 2009;74:956-962.
Lu CL, Hsieh JC, Tsaur ML, et al. Estrogen rapidly modulates mustard oil-induced visceral hypersensitivity in conscious female rats: a role of CREB phosphorylation in spinal dorsal horn neurons. Am J Physiol Gastrointest Liver Physiol 2007;292:G438-G446.
Lu CL, Hsieh JC, Dun NJ, et al. Estrogen rapidly modulates 5-hydroxytrytophan-induced visceral hypersensitivity via GPR30 in rats. Gastroenterology 2009;137:1040-1050.
Ball CL, Ness TJ, Randich A. Opioid blockade and inflammation reveal estrous cycle effects on visceromotor reflexes evoked by bladder distention. J Urol 2010;184:1529-1535.
Robbins MT, Mebane H, Ball CL, et al. Effect of estrogen on bladder nociception in rats. J Urol 2010;183:1201-1205.
Peng HY, Huang PC, Liao JM, et al. Estrous cycle variation of TRPV1-mediated cross-organ sensitization between uterus and NMDA-dependent pelvic-urethra reflex activity. Am J Physiol Endocrinol Metab 2008;295:E559-E568.
Peng HY, Chen GD, Lai CY, et al. PI3K modulates estrogen-dependent facilitation of colon-to-urethra cross-organ reflex sensitization in ovariectomized female rats. J Neurochem 2010;113:54-66.
Lin SY, Chen GD, Liao JM, et al. Estrogen modulates the spinal N-methyl-D-aspartic acid-mediated pelvic nerve-to-urethra reflex plasticity in rats. Endocrinology 2006;147:2956-2963.
Berkley KJ, McAllister SL, Accius BE, et al. Endometriosis-induced vaginal hyperalgesia in the rat: effect of estropause, ovariectomy, and estradiol replacement. Pain 2007;132:S150-S159.
Bradshaw HB, Berkley KJ. Estrogen replacement reverses ovariectomy-induced vaginal hyperalgesia in the rat. Maturitas 2002;41:157-165.
Cao DY, Ji Y, Tang B, et al. Estrogen receptor ? activation is antinociceptive in a model of visceral pain in the rat. J Pain 2012;13:685-694.
Mogil JS, Bailey AL. Sex and gender differences in pain and analgesia. Prog Brain Res 2010;186:141-157.
DeLeo JA, Rutkowski MD. Gender differences in rat neuropathic pain sensitivity is dependent on strain. Neurosci Lett 2000;282:197-199.
Leo S, Straetemans R, D’Hooge R, et al. Differences in nociceptive behavioral performance between C57BL/6J, 129S6/SvEv, B6 129 F1 and NMRI mice. Behav Brain Res 2008;190:233-242.
Mogil JS, Miermeister F, Seifert F, et al. Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proc Natl Acad Sci U S A 2005;102:12938-12943.
Vendruscolo LF, Pamplona FA, Takahashi RN. Strain and sex differences in the expression of nociceptive behavior and stress-induced analgesia in rats. Brain Res 2004;1030:277-283.
Dahan A, Kest B, Waxman AR, et al. Sex-specific responses to opiates: animal and human studies. Anesth Analg 2008;107:83-95.
Lee CW, Ho IK. Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors. Mol Pain 2013;9:45.
Kest B, Wilson SG, Mogil JS. Sex differences in supraspinal morphine analgesia are dependent on genotype. J Pharmacol Exp Ther 1999;289:1370-1375.
Auh QS, Ro JY. Effects of peripheral kappa opioid receptor activation on inflammatory mechanical hyperalgesia in male and female rats. Neurosci Lett 2012;524:111-115.
Chakrabarti S, Liu NJ, Gintzler AR. Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia. Proc Natl Acad Sci U S A 2010;107:20115-20119.
Liu NJ, Chakrabarti S, Schnell S, et al. Spinal synthesis of estrogen and concomitant signaling by membrane estrogen receptors regulate spinal kappa- and mu-opioid receptor heterodimerization and female-specific spinal morphine antinociception. J Neurosci 2011;31:11836-11845.
Lawson KP, Nag S, Thompson AD, et al. Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia. Pain 2010;151:806-815.
Mogil JS, Chesler EJ, Wilson SG, et al. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci Biobehav Rev 2000;24:375-389.
Gintzler AR, Schnell SA, Gupta DS, et al. Relationship of spinal dynorphin neurons to delta-opioid receptors and estrogen receptor alpha: anatomical basis for ovarian sex steroid opioid antinociception. J Pharmacol Exp Ther 2008;326:725-731.
Dawson-Basoa M, Gintzler AR. Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation. Brain Res 1997;757:37-42.
Mogil JS, Wilson SG, Chesler EJ, et al. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci U S A 2003;100:4867-4872.
Delaney A, Keighren M, Fleetwood-Walker SM, et al. Involvement of the melanocortin-1 receptor in acute pain and pain of inflammatory but not neuropathic origin. PLoS One 2010;5:e12498.
Belfer I, Segall SK, Lariviere WR, et al. Pain modality- and sex-specific effects of COMT genetic functional variants. Pain 2013;154:1368-1376.
Dina OA, Aley KO, Isenberg W, et al. Sex hormones regulate the contribution of PKCepsilon and PKA signalling in inflammatory pain in the rat. Eur J Neurosci 2001;13:2227-2233.
Ferhatovic L, Banozic A, Kostic S, et al. Sex differences in pain-related behavior and expression of calcium/calmodulin-dependent protein kinase II in dorsal root ganglia of rats with diabetes type 1 and type 2. Acta Histochem 2013;115:496-504.
Goswami C, Kuhn J, Dina OA, et al. Estrogen destabilizes microtubules through an ion-conductivity-independent TRPV1 pathway. J Neurochem 2011;117:995-1008.
Hucho TB, Dina OA, Kuhn J, et al. Estrogen controls PKCepsilon-dependent mechanical hyperalgesia through direct action on nociceptive neurons. Eur J Neurosci 2006;24:527-534.
Xu S, Cheng Y, Keast JR, et al. 17beta-estradiol activates estrogen receptor beta-signalling and inhibits transient receptor potential vanilloid receptor 1 activation by capsaicin in adult rat nociceptor neurons. Endocrinology 2008;149:5540-5548.
McRoberts JA, Li J, Ennes HS, et al. Sex-dependent differences in the activity and modulation of N-methyl-d-aspartic acid receptors in rat dorsal root ganglia neurons. Neuroscience 2007;148:1015-1020.
Dong XD, Mann MK, Kumar U, et al. Sex-related differences in NMDA-evoked rat masseter muscle afferent discharge result from estrogen-mediated modulation of peripheral NMDA receptor activity. Neuroscience 2007;146:822-832.
Castrillon EE, Cairns BE, Wang K, et al. Comparison of glutamate-evoked pain between the temporalis and masseter muscles in men and women. Pain 2012;153:823-829.
Svensson P, Cairns BE, Wang K, et al. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain 2003;101:221-227.
Lei J, Jin L, Zhao Y, et al. Sex-related differences in descending norepinephrine and serotonin controls of spinal withdrawal reflex during intramuscular saline induced muscle nociception in rats. Exp Neurol 2011;228:206-214.
Spinelli S, Schwandt ML, Lindell SG, et al. The serotonin transporter gene linked polymorphic region is associated with the behavioral response to repeated stress exposure in infant rhesus macaques. Dev Psychopathol 2012;24:157-165.
Sorge RE, LaCroix-Fralish ML, Tuttle AH, et al. Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice. J Neurosci 2011;31:15450-15454.
Burnes LA, Kolker SJ, Danielson JF, et al. Enhanced muscle fatigue occurs in male but not female ASIC3-/- mice. Am J Physiol Regul Integr Comp Physiol 2008;294:R1347-R1355.
Niu KY, Zhang Y, Ro JY. Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats. Pain 2012;153:2283-2291.
Cairns BE, Sim Y, Bereiter DA, et al. Influence of sex on reflex jaw muscle activity evoked from the rat temporomandibular joint. Brain Res 2002;957:338-344.
Gaumond I, Arsenault P, Marchand S. The role of sex hormones on formalin-induced nociceptive responses. Brain Res 2002;958:139-145.
Coulombe MA, Spooner MF, Gaumond I, et al. Estrogen receptors beta and alpha have specific pro- and anti-nociceptive actions. Neuroscience 2011;184:172-182.
Zhang Y, Lü N, Zhao ZQ, et al. Involvement of estrogen in rapid pain modulation in the rat spinal cord. Neurochem Res 2012;37:2697-2705.
Joseph EK, Levine JD. Sexual dimorphism for protein kinase C? signaling in a rat model of vincristine-induced painful peripheral neuropathy. Neuroscience 2003;119:831-838.
Spooner MF, Robichaud P, Carrier JC, et al. Endogenous pain modulation during the formalin test in estrogen receptor beta knockout mice. Neuroscience 2007;150:675-680.
Gaumond I, Arsenault P, Marchand S. Specificity of female and male sex hormones on excitatory and inhibitory phases of formalin-induced nociceptive responses. Brain Res 2005;1052:105-111.
Pajot J, Ressot C, Ngom I, et al. Gonadectomy induces site-specific differences in nociception in rats. Pain 2003;104:367-373.
Ma B, Yu L, Fan J, et al. Estrogen modulation of peripheral pain signal transduction: Involvement of P2X3 receptors. Purinergic Signal 2011;7:73-83.
Fischer L, Torres-Chávez KE, Clemente-Napimoga JT, et al. The influence of sex and ovarian hormones on temporomandibular joint nociception in rats. J Pain 2008;9:630-638.
Aloisi AM, Ceccarelli I, Fiorenzani P. Gonadectomy affects hormonal and behavioral responses to repetitive nociceptive stimulation in male rats. Ann NY Acad Sci. Volume 1007, 2003:232-237.
Ceccarelli I, Fiorenzani P, Massafra C, et al. Repeated nociceptive stimulation induces different behavioral and neuronal responses in intact and gonadectomized female rats. Brain Res 2006;1106:142-149.
Ceccarelli I, Fiorenzani P, Massafra C, et al. Long-term ovariectomy changes formalin-induced licking in female rats: the role of estrogens. Reprod Biol Endocrinol 2003;1:24.
Kuba T, Kemen LM, Quinones-Jenab V. Estradiol administration mediates the inflammatory response to formalin in female rats. Brain Res 2005;1047:119-122.
Mannino CA, South SM, Quinones-Jenab V, et al. Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin test. J Pain 2007;8:334-342.
Sanoja R, Cervero F. Estrogen-dependent abdominal hyperalgesia induced by ovariectomy in adult mice: a model of functional abdominal pain. Pain 2005;118:243-253.
Fischer L, Clemente JT, Tambeli CH. The protective role of testosterone in the development of temporomandibular joint pain. J Pain 2007;8:437-442.
Salomaa S, Pekki A, Sannisto T, et al. Progesterone receptor is constitutively expressed in chicken intestinal mesothelium and smooth muscle. J Steroid Biochem 1989;34:345-349.
Winborn WB, Sheridan PJ, McGill HC, Jr. Sex steroid receptors in the stomach, liver, pancreas, and gastrointestinal tract of the baboon. Gastroenterology 1987;92:23-32.
Ryan JP, Bhojwani A. Colonic transit in rats: effect of ovariectomy, sex steroid hormones, and pregnancy. Am J Physiol 1986;251:G46-50.
Gual O, Bozkurt A, Deniz M, et al. Effect of sex steroids on colonic distension-induced delay of gastric emptying in rats. J Gastroenterol Hepatol 2004;19:975-981.
Tache Y, Million M, Nelson AG, et al. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents. Gend Med 2005;2:146-154.
Stam R, Croiset G, Bruijnzeel A, et al. Sex differences in long-term stress-induced colonic, behavioural and hormonal disturbances. Life Sci 1999;65:2837-2849.
Metcalf AM, Phillips SF, Zinsmeister AR, et al. Simplified assessment of segmental colonic transit. Gastroenterology 1987;92:40-47.
Shah S, Nathan L, Singh R, et al. E2 and not P4 increases NO release from NANC nerves of the gastrointestinal tract: implications in pregnancy. Am J Physiol Regul Integr Comp Physiol 2001;280:R1546-R1554.
Bradesi S, Eutamene H, Theodorou V, et al. Effect of ovarian hormones on intestinal mast cell reactivity to substance P. Life Sci 2001;68:1047-1056.
Gill RC, Bowes KL, Kingma YJ. Effect of progesterone on canine colonic smooth muscle. Gastroenterology 1985;88:1941-1947.
Braniste V, Leveque M, Buisson-Brenac C, et al. Oestradiol decreases colonic permeability through oestrogen receptor ?-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells. J Physiol 2009;587:3317-3328.
Homma H, Hoy E, Xu D-Z, et al. The female intestine is more resistant than the male intestine to gut injury and inflammation when subjected to conditions associated with shock states. Am J Physiol Gastrointest Liver Physiol 2005;288:G466-G472.
Cook LC, Hillhouse AE, Myles MH, et al. The role of estrogen signaling in a mouse model of inflammatory bowel disease: a Helicobacter hepaticus model. PLoS One 2014;9:e94209.
Krarup AL, Gunnarsson J, Brun J, et al. Exploration of the effects of gender and mild esophagitis on esophageal pain thresholds in the normal and sensitized state of asymptomatic young volunteers. Neurogastroenterol Motil 2013;25:766-e580.
Nguyen P, Lee SD, Castell DO. Evidence of gender differences in esophageal pain threshold. Am J Gastroenterol 1995;90:901-905.
Pedersen J, Reddy H, Funch-Jensen P, et al. Differences between male and female responses to painful thermal and mechanical stimulation of the human esophagus. Dig Dis Sci 2004;49:1065-1074.
Reddy H, Arendt-Nielsen L, Staahl C, et al. Gender differences in pain and biomechanical responses after acid sensitization of the human esophagus. Dig Dis Sci 2005;50:2050-2058.
Rao SS, Mudipalli RS, Mujica VR, et al. Effects of gender and age on esophageal biomechanical properties and sensation. Am J Gastroenterol 2003;98:1688-1695.
Mearadji B, Penning C, Vu MK, et al. Influence of gender on proximal gastric motor and sensory function. Am J Gastroenterol 2001;96:2066-2073.
Benson S, Kotsis V, Rosenberger C, et al. Behavioural and neural correlates of visceral pain sensitivity in healthy men and women: does sex matter? Eur J Pain 2012;16:349-358.
Chang L, Mayer EA, Labus JS, et al. Effect of sex on perception of rectosigmoid stimuli in irritable bowel syndrome. Am J Physiol Regul Integr Comp Physiol 2006;291:R277-R284.
Kern MK, Jaradeh S, Arndorfer RC, et al. Gender differences in cortical representation of rectal distension in healthy humans. Am J Physiol Gastrointest Liver Physiol 2001;281:G1512-G1523.
Sloots CE, Felt-Bersma RJ, Cuesta MA, et al. Rectal visceral sensitivity in healthy volunteers: influences of gender, age and methods. Neurogastroenterol Motil 2000;12:361-368.
Soffer EE, Kongara K, Achkar JP, et al. Colonic motor function in humans is not affected by gender. Dig Dis Sci 2000;45:1281-1284.
Gundling F, Seidl H, Scalercio N, et al. Influence of gender and age on anorectal function: normal values from anorectal manometry in a large caucasian population. Digestion 2010;81:207-213.
Kim HS, Rhee PL, Park J, et al. Gender-related differences in visceral perception in health and irritable bowel syndrome. J Gastroenterol Hepatol 2006;21:468-473.
Mulak A, Paradowski, L. Anorectal function in the irritable bowel syndrome depending on patients gender and age. Gastroenterologica Polska 2007;14:107-110.
Posserud I, Syrous A, Lindstrom L, et al. Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology 2007;133:1113-1123.
Ragnarsson G, Hallbook O, Bodemar G. Abdominal symptoms are not related to anorectal function in the irritable bowel syndrome. Scand J Gastroenterol 1999;34:250-258.
Berman S, Munakata J, Naliboff BD, et al. Gender differences in regional brain response to visceral pressure in IBS patients. Eur J Pain 2000;4:157-172.
Mertz H, Naliboff B, Munakata J, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52.
Munakata J, Naliboff B, Harraf F, et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology 1997;112:55-63.
Naliboff BD, Berman S, Suyenobu B, et al. Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterology 2006;131:352-365.
Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol 1997;92:954-959.
Racine M, Tousignant-Laflamme Y, Kloda LA, et al. A systematic literature review of 10 years of research on sex/gender and experimental pain perception – part 1: are there really differences between women and men? Pain 2012;153:602-618.
Mogil JS. Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon. Nat Rev Neurosci 2012;13:859-866.
Stabell N, Stubhaug A, Flaegstad T, et al. Increased pain sensitivity among adults reporting irritable bowel syndrome symptoms in a large population-based study. Pain 2013;154:385-392.
Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth 2013;111:52-58.
Diamant NE. Physiology of the esophagus. In: Sleisenger M, Fordtran J, eds. Gastrointestinal disease. Philadelphia, PA: WB Saunders Company, 1993.
Dantas RO, Ferriolli E, Souza MA. Gender effects on esophageal motility. Braz J Med Biol Res 1998;31:539-544.
Vega KJ, Palacio C, Langford-Legg T, et al. Gender variation in oesophageal motor function: analysis of 129 healthy individuals. Dig Liver Dis 2010;42:482-484.
Bennink R, Peeters M, Van den Maegdenbergh V, et al. Comparison of total and compartmental gastric emptying and antral motility between healthy men and women. Eur J Nucl Med 1998;25:1293-1299.
Datz FL, Christian PE, Moore J. Gender-related differences in gastric emptying. J Nucl Med 1987;28:1204-1207.
Degen LP, Phillips SF. Variability of gastrointestinal transit in healthy women and men. Gut 1996;39:299-305.
Hermansson G, Sivertsson R. Gender-related differences in gastric emptying rate of solid meals. Dig Dis Sci 1996;41:1994-1998.
Hutson WR, Roehrkasse RL, Wald A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology 1989;96:11-17.
Knight LC, Parkman HP, Brown KL, et al. Delayed gastric emptying and decreased antral contractility in normal premenopausal women compared with men. Am J Gastroenterol 1997;92:968-975.
Wedmann B, Schmidt G, Wegener M, et al. Effects of age and gender on fat-induced gallbladder contraction and gastric emptying of a caloric liquid meal: a sonographic study. Am J Gastroenterol 1991;86:1765-1770.
Pataramon V, Tawatchai C, Pawana P, et al. Normal solid gastric emptying values measured by scintigraphy using Asian-style MEAL: a multicenter study in healthy volunteers. J Neurogastroenterol Motil 2014;20:371-378.
Camilleri M, Iturrino J, Bharucha AE, et al. Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol Motil 2012;24:1076-e1562.
Teff KL, Alavi A, Chen J, et al. Muscarinic blockade inhibits gastric emptying of mixed-nutrient meal: effects of weight and gender. Am J Physiol 1999;276:R707-R714.
Lampe JW, Fredstrom SB, Slavin JL, et al. Sex differences in colonic function: a randomised trial. Gut 1993;34:531-536.
Meier R, Beglinger C, Dederding JP, et al. Influence of age, gender, hormonal status and smoking habits on colonic transit time. Neurogastroenterol Motil 1995;7:235-238.
Rao SS, Sadeghi P, Beaty J, et al. Ambulatory 24-hour colonic manometry in slow-transit constipation. Am J Gastroenterol 2004;99:2405-2416.
Sun WM, Read NW. Anorectal function in normal human subjects: effect of gender. Int J Colorectal Dis 1989;4:188-196.
Li Y, Yang X, Xu C, et al. Normal values and pressure morphology for three-dimensional high-resolution anorectal manometry of asymptomatic adults: a study in 110 subjects. Int J Colorectal Dis 2013;28:1161-1168.
Lee HR, Lim SB, Park JY. Anorectal manometric parameters are influenced by gender and age in subjects with normal bowel function. Int J Colorectal Dis 2014;29:1393-1399.
Mazurak N, Seredyuk N, Sauer H, et al. Heart rate variability in the irritable bowel syndrome: a review of the literature. Neurogastroenterol Motil 2012;24:206-216.
Dal K, Deveci OS, Kucukazman M, et al. Decreased parasympathetic activity in patients with functional dyspepsia. Eur J Gastroenterol Hepatol 2014;26:748-752.
Tillisch K, Mayer EA, Labus JS, et al. Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut 2005;54:1396-1401.
Cheng P, Shih W, Alberto M, et al. Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of disease. Neurogastroenterol Motil 2013;25:e650-e659.
Heitkemper M, Jarrett M, Cain KC, et al. Autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci 2001;46:1276-1284.
Elsenbruch S, Orr WC. Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses. Am J Gastroenterol 2001;96:460-466.
Berman SM, Naliboff BD, Suyenobu B, et al. Sex differences in regional brain response to aversive pelvic visceral stimuli. Am J Physiol Regul Integr Comp Physiol 2006;291:R268-R276.
Kano M, Farmer AD, Aziz Q, et al. Sex differences in brain response to anticipated and experienced visceral pain in healthy subjects. Am J Physiol Gastrointest Liver Physiol 2013;304:G687-G699.
Hobson AR, Furlong PL, Worthen SF, et al. Real-time imaging of human cortical activity evoked by painful esophageal stimulation. Gastroenterology 2005;128:610-619.
Hong JY, Kilpatrick LA, Labus J, et al. Patients with chronic visceral pain show sex-related alterations in intrinsic oscillations of the resting brain. J Neurosci 2013;33:11994-12002.
Hong JY, Kilpatrick LA, Labus JS, et al. Sex and disease-related alterations of anterior insula functional connectivity in chronic abdominal pain. J Neurosci 2014;34:14252-14259.
Jiang Z, Dinov ID, Labus J, et al. Sex-related differences of cortical thickness in patients with chronic abdominal pain. PLoS One 2013;8:e73932.
Elsenbruch S, Schmid J, Kullmann JS, et al. Visceral sensitivity correlates with decreased regional gray matter volume in healthy volunteers: a voxel-based morphometry study. Pain 2013.
Naliboff BD, Berman S, Chang L, et al. Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology 2003;124:1738-1747.
Labus JS, Naliboff BN, Fallon J, et al. Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis. Neuroimage 2008;41:1032-1043.
Labus JS, Gupta A, Coveleskie K, et al. Sex differences in emotion-related cognitive processes in irritable bowel syndrome and healthy control subjects. Pain 2013;154:2088-2099.
Gupta A, Kilpatrick L, Labus J, et al. Early adverse life events and resting state neural networks in patients with chronic abdominal pain: evidence for sex differences. Psychosom Med 2014;76:404-412.
Intentionally blank.
Blankstein U, Chen J, Diamant NE, et al. Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors. Gastroenterology 2010;138:1783-1789.
Davis KD, Pope G, Chen J, et al. Cortical thinning in IBS: implications for homeostatic, attention, and pain processing. Neurology 2008;70:153-154.
Seminowicz DA, Labus JS, Bueller JA, et al. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology 2010;139:48-57 e42.
Labus JS, Dinov ID, Jiang Z, et al. Irritable bowel syndrome in female patients is associated with alterations in structural brain networks. Pain 2014;155:137-149.
Ellingson BM, Mayer E, Harris RJ, et al. Diffusion tensor imaging detects microstructural reorganization in the brain associated with chronic irritable bowel syndrome. Pain 2013;154:1528-1541.
Larsson MB, Tillisch K, Craig AD, et al. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology 2012;142:463-472 e463.
Saito YA, Zimmerman JM, Harmsen WS, et al. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil 2008;20:790-797.
Saito YA. The role of genetics in IBS. Gastroenterol Clin North Am 2011;40:45-67.
Lembo A, Zaman M, Jones M, et al. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther 2007;25:1343-1350.
Gathaiya N, Locke GR 3rd, Camilleri M, et al. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil 2009;21:922-e969.
Oshima T, Toyoshima F, Nakajima S, et al. Genetic factors for functional dyspepsia. J Gastroenterol Hepatol 2011;26(Suppl 3):83-87.
Saito YA, Petersen GM, Larson JJ, et al. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol 2010;105:833-841.
Svedberg P, Johansson S, Wallander MA, et al. No evidence of sex differences in heritability of irritable bowel syndrome in Swedish twins. Twin Res Hum Genet 2008;11:197-203.
Mulak A, Tache Y, Larauche M. Sex hormones in the modulation of irritable bowel syndrome. World J Gastroenterol 2014;20:2433-2448.
Evans J, Salamonsen LA. Inflammation, leukocytes and menstruation. Rev Endocr Metab Disord 2012;13:277-288.
Whitcomb BW, Mumford SL, Perkins NJ, et al. Urinary cytokine and chemokine profiles across the menstrual cycle in healthy reproductive-aged women. Fertil Steril 2014;101(5):1383-1391381.
Barbara G, Cremon C, Carini G, et al. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil 2011;17:349-359.
Chang L, Adeyemo M, Karagiannides I, et al. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol 2012;107:262-272.
Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009;104:392-400.
Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2013;305:G529-G541.
Adam B, Tsopelas C, Liebregts T, et al. Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndrome. J Gastroenterol 2013;48:1119-1127.
Spiller R, Lam C. An update on post-infectious irritable bowel syndrome: role of genetics, immune activation, serotonin and altered microbiome. J Neurogastroenterol Motil 2012;18:258-268.
Flores R, Shi J, Fuhrman B, et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med 2012;10:253.
Flak MB, Neves JF, Blumberg RS. Immunology. Welcome to the microgenderome. Science 2013;339:1044-1045.
Farage MA, Neill S, MacLean AB. Physiological changes associated with the menstrual cycle: a review. Obstet Gynecol Surv 2009;64:58-72.
Moore J, Barlow D, Jewell D, et al. Do gastrointestinal symptoms vary with the menstrual cycle? Br J Obstet Gynaecol 1998;105:1322-1325.
Chang L, Lee OY, Naliboff B, et al. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol 2001;96:3341-3347.
Ouyang A, Wrzos HF. Contribution of gender to pathophysiology and clinical presentation of IBS: should management be different in women? Am J Gastroenterol 2006;101:S602-S609.
Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol 1998;93:1867-1872.
Chiloiro M, Darconza G, Piccioli E, et al. Gastric emptying and orocecal transit time in pregnancy. J Gastroenterol 2001;36:538-543.
Ter Horst GJ, Wichmann R, Gerrits M, et al. Sex differences in stress responses: focus on ovarian hormones. Physiol Behav 2009;97:239-249.
Gonenne J, Esfandyari T, Camilleri M, et al. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil 2006;18:911-918.
Ruigomez A, Garcia Rodriguez LA, Johansson S, et al. Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome? Maturitas 2003;44:133-140.
Kim BJ, Rhee PL, Park JH, et al. Male sex hormones may influence the symptoms of irritable bowel syndrome in young men. Digestion 2008;78:88-92.
Aloisi AM, Bachiocco V, Costantino A, et al. Cross-sex hormone administration changes pain in transsexual women and men. Pain 2007;132 Suppl 1:S60-S67.
Gooren LJ, Sungkaew T, Giltay EJ, et al. Cross-sex hormone use, functional health and mental well-being among transgender men (Toms) and transgender women (Kathoeys) in Thailand. Cult Health Sex 2015;17:92-103.
Aloisi AM. Gonadal hormones and sex differences in pain reactivity. Clin J Pain 2003;19:168-174.
Cairns BE, Gazerani P. Sex-related differences in pain. Maturitas 2009;63:292-296.
Rybaczyk LA, Bashaw MJ, Pathak DR, et al. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Women’s Health 2005;5:12.
Goldstein JM, Jerram M, Abbs B, et al. Sex differences in stress response circuitry activation dependent on female hormonal cycle. J Neurosci 2010;30:431-438.
Chen X-N, Zhu H, Meng Q-Y, et al. Estrogen receptor-? and -? regulate the human corticotropin-releasing hormone gene through similar pathways. Brain Res 2008;1223:1-10.
Pfaffl MW, Lange IG, Meyer HHD. The gastrointestinal tract as target of steroid hormone action: quantification of steroid receptor mRNA expression (AR, ER?, ER? and PR) in 10 bovine gastrointestinal tract compartments by kinetic RT-PCR. J Steroid Biochem Mol Biol 2003;84:159-166.
McEwen BS. Estrogens effects on the brain: multiple sites and molecular mechanisms, 2012.
Viau V, Meaney MJ. The inhibitory effect of testosterone on hypothalamic-pituitary-adrenal responses to stress is mediated by the medial preoptic area. J Neurosci 1996;16:1866-1876.
Fillingim RB, King CD, Ribeiro-Dasilva MC, et al. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 2009;10:447-485.
Rydlewska A, Maj J, Katkowski B, et al. Circulating testosterone and estradiol, autonomic balance and baroreflex sensitivity in middle-aged and elderly men with heart failure. Aging Male 2013;16:58-66.
Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007;28:521-574.
Bao A-M, Hestiantoro A, Van Someren EJ, et al. Colocalization of corticotropin-releasing hormone and oestrogen receptor-? in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 2005;128:1301-1313.
Li T-J, Yu B-P, Dong W-G, et al. Ovarian hormone modulates 5-hydroxytryptamine 3 receptors mRNA expression in rat colon with restraint stress-induced bowel dysfunction. World J Gastroenterol 2004;10:2723-2726.
Levin ER. Membrane oestrogen receptor ? signalling to cell functions. J Physiol 2009;587:5019-5023.
Houdeau E, Moriez R, Leveque M, et al. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat. Gastroenterology 2007;132:982-993.
Cong P, Pricolo V, Biancani P, et al. Abnormalities of prostaglandins and cyclooxygenase enzymes in female patients with slow-transit constipation. Gastroenterology 2007;133:445-453.
Vasiadi M, Kempuraj D, Boucher W, et al. Progesterone inhibits mast cell secretion. Int J Immunopathol Pharmacol 2005;19:787-794.
Su L, Sun Y, Ma F, et al. Progesterone inhibits toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-?B activation and enhancing SOCS1 expression. Immunol Lett 2009;125:151-155.
Vodo S, Bechi N, Petroni A, et al. Testosterone-induced effects on lipids and inflammation. Mediators Inflamm 2013;2013.
Chen W, Beck I, Schober W, et al. Human mast cells express androgen receptors but treatment with testosterone exerts no influence on IgE?independent mast cell degranulation elicited by neuromuscular blocking agents. Exp Dermatol 2010;19:302-304.
Rettew JA, Huet-Hudson YM, Marriott I. Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reprod 2008;78:432-437.
Menon R, Watson SE, Thomas LN, et al. Diet complexity and estrogen receptor ?-status affect the composition of the murine intestinal microbiota. Appl Environ Microbiol 2013:AEM. 01182-01113.
García-Gómez E, González-Pedrajo B, Camacho-Arroyo I. Role of sex steroid hormones in bacterial-host interactions. Biomed Res Int 2013;2013:10.
Donova M, Egorova O. Microbial steroid transformations: current state and prospects. Appl Microbiol Biotechnol 2012;94:1423-1447.
Markle JGM, Frank DN, Mortin-Toth S, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013;339:1084-1088.
Goff BA. Ovarian cancer: screening and early detection. Obstet Gynecol Clin North Am 2012;39:183-194.
Gaylord SA, Palsson OS, Garland EL, et al. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol 2011;106:1678-1688.
Heitkemper MM, Jarrett ME, Levy RL, et al. Self-management for women with irritable bowel syndrome. Clin Gastroenterol Hepatol 2004;2:585-596.
van der Veek SM, Derkx BH, Benninga MA, et al. Cognitive behavior therapy for pediatric functional abdominal pain: a randomized controlled trial. Pediatrics 2013;132:e1163-e1172.
Ford AC, Quigley EM, Lacy BE, et al. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2014;109:1350-1365; quiz 1366.
Blanchard EB, Keefer L, Galovski TE, et al. Gender differences in psychological distress among patients with irritable bowel syndrome. J Psychosom Res 2001;50:271-275.
Corney RH. Sex differences in general practice attendance and help seeking for minor illness. J Psychosom Res 1990;34:525-534.
Lackner JM, Gudleski GD, Keefer L, et al. Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2010;8:426-432.
Jarrett ME, Cain KC, Burr RL, et al. Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessions. Am J Gastroenterol 2009;104:3004-3014.
Svedlund J, Sjodin I, Ottosson JO, et al. Controlled study of psychotherapy in irritable bowel syndrome. Lancet 1983;2:589-592.
Guthrie E, Creed F, Dawson D, et al. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991;100:450-457.
Creed F, Fernandes L, Guthrie E, et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003;124:303-317.
Hamilton J, Guthrie E, Creed F, et al. A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 2000;119:661-669.
Svedlund J, Sjodin I. A psychosomatic approach to treatment in the irritable bowel syndrome and peptic ulcer disease with aspects of the design of clinical trials. Scand J Gastroenterol Suppl 1985;109:147-151.
Gonsalkorale WM, Miller V, Afzal A, et al. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003;52:1623-1629.
Moser G, Tragner S, Gajowniczek EE, et al. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2013;108:602-609.
Miller V, Carruthers HR, Morris J, et al. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther 2015;41:844-855.
Farnam A, Somi MH, Farhang S, et al. The therapeutic effect of adding emotional awareness training to standard medical treatment for irritable bowel syndrome: a randomized clinical trial. J Psychiatr Pract 2014;20:3-11.
Russo L, Andreozzi P, Zito FP, et al. Partially hydrolyzed guar gum in the treatment of irritable bowel syndrome with constipation: Effects of gender, age, and body mass index. Saudi J Gastroenterol 2015;21:104-110.
Ford AC, Talley NJ, Schoenfeld PS, et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009;58:367-378.
Jackson JL, O’Malley PG, Tomkins G, et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000;108:65-72.
Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000;133:136-147.
Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008;337:a2313.
Camilleri M, Mayer EA, Drossman DA, et al. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther 1999;13:1149-1159.
Camilleri M, Northcutt AR, Kong S, et al. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet 2000;355:1035-1040.
Chang L, Ameen VZ, Dukes GE, et al. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS. Am J Gastroenterol 2005;100:115-123.
Camilleri M, Atanasova E, Carlson PJ, et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 2002;123:425-432.
Niesler B, Kapeller J, Fell C, et al. 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene and irritable bowel syndrome: effect of bowel habit and sex. Eur J Gastroenterol Hepatol 2010;22:856-861.
Viramontes BE, Camilleri M, McKinzie S, et al. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2001;96:2671-2676.
Delvaux M, Louvel D, Mamet JP, et al. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1998;12:849-855.
Nakai A, Diksic M, Kumakura Y, et al. The effects of the 5-HT3 antagonist, alosetron, on brain serotonin synthesis in patients with irritable bowel syndrome. Neurogastroenterol Motil 2005;17:212-221.
Wheatcroft J, Wakelin D, Smith A, et al. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005;17:863-870.
Camilleri M, Kerstens R, Rykx A, et al. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008;358:2344-2354.
Quigley EM, Vandeplassche L, Kerstens R, et al. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation—a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 2009;29:315-328.
Tack J, van Outryve M, Beyens G, et al. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 2009;58:357-365.
O’Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-551.
Lunsford TN, Harris LA. Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome. Int J Womens Health 2010;2:361-374.
Wilson N, Schey R. Lubiprostone in constipation: clinical evidence and place in therapy. Ther Adv Chronic Dis 2015;6:40-50.
Chey WD, Lembo AJ, Lavins BJ, et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol 2012;107:1702-1712.
Williams ET, Leyk M, Wrighton SA, et al. Estrogen regulation of the cytochrome P450 3A subfamily in humans. J Pharmacol Exp Ther 2004;311:728-735.
Kaiser J. Gender in the pharmacy: does it matter? Science 2005;308:1572.
Alameel T, Basheikh M, Andrew MK. Digestive symptoms in older adults: prevalence and associations with institutionalization and mortality. Can J Gastroenterol 2012;26:881-884.
Agreus L, Svardsudd K, Talley NJ, et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001;96:2905-2914.
Jones R, Lydeard S, Hobbs F, et al. Dyspepsia in England and Scotland. Gut 1990;31:401-405.
Yazdanpanah K, Moghimi N, Yousefinejad V, et al. Dyspepsia prevalence in general population aged over 20 in the west part of Iran. J Pak Med Assoc 2012;62:672-676.
Roden DF, Altman KW. Causes of dysphagia among different age groups: a systematic review of the literature. Otolaryngol Clin North Am 2013;46:965-987.
Breckan RK, Asfeldt AM, Straume B, et al. Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway. Scand J Gastroenterol 2012;47:1274-1282.
Horst S, Shelby G, Anderson J, et al. Predicting persistence of functional abdominal pain from childhood into young adulthood. Clin Gastroenterol Hepatol 2014;12:2026-2032.
Yamamoto R, Kaneita Y, Osaki Y, et al. Irritable bowel syndrome among Japanese adolescents: a nationally representative survey. J Gastroenterol Hepatol 2015;Apr 13. doi: 10.1111/jgh.12974.
Naumann CR, Zelig C, Napolitano PG, et al. Nausea, vomiting, and heartburn in pregnancy: a prospective look at risk, treatment, and outcome. J Matern Fetal Neonatal Med 2012;25:1488-1493.
Cain KC, Jarrett ME, Burr RL, et al. Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome. Dig Dis Sci 2009;54:1542-1549.
Sievert LL, Obermeyer CM. Symptom clusters at midlife: a four-country comparison of checklist and qualitative responses. Menopause 2012;19:133-144.
Kjellstrom L, Molinder H, Agreus L, et al. A randomly selected population sample undergoing colonoscopy: prevalence of the irritable bowel syndrome and the impact of selection factors. Eur J Gastroenterol Hepatol 2014;26:268-275.
Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004;99:750-759.
McOmber ME, Ou CN, Shulman RJ. Effects of timing, sex, and age on site-specific gastrointestinal permeability testing in children and adults. J Pediatr Gastroenterol Nutr 2010;50:269-275.
Biagi E, Nylund L, Candela M, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010;5:e10667.
Gavini F, Cayuela, C., Antoine, JM, Lecoq, C., Lefebvre, B, Membre, JM, Neut, C. Differences in the distribution of bifidobacterial and enterobacterial species in human faecal microflora of three different (children, adults, elderly) age groups. Microb Ecol Health Dis 2001;13:40-45.
Mariat D, Firmesse O, Levenez F, et al. The firmicutes/bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 2009;9:123.
Woodmansey EJ, McMurdo ME, Macfarlane GT, et al. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 2004;70:6113-6122.
Mueller S, Saunier K, Hanisch C, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 2006;72:1027-1033.
Makivuokko H, Tiihonen K, Tynkkynen S, et al. The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition. Br J Nutr 2010;103:227-234.
Candela M, Turroni S, Biagi E, et al. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol 2014;20:908-922.
Markland AD, Palsson O, Goode PS, et al. Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol 2013;108:796-803.
Ilnyckyj A. Prevalence of idiopathic fecal incontinence in a community-based sample. Can J Gastroenterol 2010;24:251-254.
Matthews CA, Whitehead WE, Townsend MK, et al. Risk factors for urinary, fecal, or dual incontinence in the Nurses’ Health Study. Obstet Gynecol 2013;122:539-545.
Horng SS, Chou YJ, Huang N, et al. Fecal incontinence epidemiology and help seeking among older people in Taiwan. Neurourol Urodyn 2013;33:1153-1158.
De Vogli R, Chandola T, Marmot MG. Negative aspects of close relationships and heart disease. Arch Intern Med 2007;167:1951-1957.
Theysohn N, Schmid J, Icenhour A, et al. Are there sex differences in placebo analgesia during visceral pain processing? A fMRI study in healthy subjects. Neurogastroenterol Motil 2014;26:1743-1753.
Yawn BP, Locke GR 3rd, Lydick E, et al. Diagnosis and care of irritable bowel syndrome in a community-based population. Am J Manag Care 2001;7:585-592.
Lips H. Sex and gender. Mountain View, CA: Mayfield Publishing, 1997.

You must be logged in with a subscription to access this page. Click here to login.